Back to VIR

CITADEL ADVISORS LLC → VIR

CITADEL ADVISORS LLC VIR Position History

Vir Biotechnology, Inc. • Healthcare

Quarters held
13
Latest value
$162K
Q3 2026
Peak value
$15.9M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$15.9M
Q1 2026$2.9M
Q1 2026$944K
Q2 2026$7.7M
Q2 2026$543K
Q2 2026$2.4M
Q2 2026$7.7M
Q2 2026$543K
Q2 2026$2.4M
Q3 2026$4M
Q3 2026$735K
Q3 2026$532K
Q3 2026$162K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$162K14.5K——
Q3 2026$532K47.6K——
Q3 2026$735K65.7K——
Q3 2026$4M355.0K——
Q2 2026$2.4M235.9K——
Q2 2026$543K53.3K——
Q2 2026$7.7M755.5K——
Q2 2026$2.4M235.9K——
Q2 2026$543K53.3K——
Q2 2026$7.7M755.5K——
Q1 2026$944K105.4K——
Q1 2026$2.9M323.0K——
Q1 2026$15.9M1.78M——

Other funds holding VIR

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B